Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

D Stolz, T Mkorombindo, DM Schumann, A Agusti… - The Lancet, 2022 - thelancet.com
Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …

[HTML][HTML] Stressed out-The role of oxidative stress in airway smooth muscle dysfunction in asthma and COPD

RM Saunders, M Biddle, Y Amrani… - Free Radical Biology and …, 2022 - Elsevier
The airway smooth muscle (ASM) surrounding the airways is dysfunctional in both asthma
and chronic obstructive pulmonary disease (COPD), exhibiting; increased contraction …

An update on outcomes for COPD pharmacological trials: a COPD investigators report-reassessment of the 2008 American Thoracic Society/European Respiratory …

M Cazzola, P Rogliani, PJ Barnes, F Blasi… - American Journal of …, 2023 - atsjournals.org
Background: In 2008, a dedicated American Thoracic Society/European Respiratory Society
task force published a paper on the possible use and limitations of clinical outcomes and …

Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases

DS Dhanjal, P Sharma, M Mehta… - Future Medicinal …, 2022 - Taylor & Francis
Chronic respiratory disorders affect millions of people worldwide. Pathophysiological
changes to the normal airway wall structure, including changes in the composition and …

Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities

LY Lee, GSY Hew, M Mehta, SD Shukla, S Satija… - Life sciences, 2021 - Elsevier
Eosinophils are bi-lobed, multi-functional innate immune cells with diverse cell surface
receptors that regulate local immune and inflammatory responses. Several inflammatory and …

Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously

L Wang, X Chen, X Li, D Liu, X Wang, X Chang… - Free Radical Biology …, 2021 - Elsevier
Chronic obstructive pulmonary disease (COPD) is estimated to be the sixth major cause of
disability, and the third main cause of death in the world by 2020. Although both …

No independent influence of statins on the chronic obstructive pulmonary disease exacerbation rate: a cohort observation study over 10 years

J Yayan, M Bald, KJ Franke - International Journal of General …, 2021 - Taylor & Francis
Purpose Some previously published primarily retrospective studies have shown that statins
could reduce the rate and severity of exacerbations, the length of hospital stays, and …

Evaluating novel protein phosphatase 2A activators as therapeutics for emphysema

B Soto, H Ahmed, M Pillai, SS Park… - American Journal of …, 2023 - atsjournals.org
The activity of PP2A (protein phosphatase 2A), a serine-threonine phosphatase, is reduced
by chronic cigarette smoke (SM) exposure and α-1 antitrypsin (AAT) deficiency, and …

A systematic and critical review of discrete choice experiments in asthma and chronic obstructive pulmonary disease

H Collacott, D Zhang, S Heidenreich… - The Patient-Patient …, 2022 - Springer
Background Regulators have called for greater emphasis on the role of the patient voice to
inform medical product development and decision making, and expert guidelines and …

Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH

S Zhou, Q Zhang, H Yang, Y Zhu, X Hu, G Wan, L Yu - Life Sciences, 2024 - Elsevier
Pulmonary disorders, including asthma, chronic obstructive pulmonary disease (COPD),
pulmonary fibrosis (PF), pulmonary hypertension (PH), and lung cancer, seriously impair the …